[MCOH-EH] COVID Vaccination Dose #2 in employees who become positive after dose #1

[Richardson, Amy]

See below CDC recommendations:
Vaccination of persons with a SARS-CoV-2 infection or exposure
Persons with a current or prior history of SARS-CoV-2 infection
Data from clinical trials indicate that mRNA COVID-19 vaccines are safe in persons with evidence of a prior SARS-CoV-2 infection. Vaccination should be offered to persons regardless of history of prior symptomatic or asymptomatic SARS-CoV-2 infection. Viral testing to assess for acute SARS-CoV-2 infection or serologic testing to assess for prior infection solely for the purposes of vaccine decision-making is not recommended.
Vaccination of persons with known current SARS-CoV-2 infection should be deferred until the person has recovered from the acute illness (if the person had symptoms) and criteria<https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-in-home-patients.html> have been met for them to discontinue isolation. This recommendation applies to persons who develop SARS-CoV-2 infection before receiving any vaccine doses as well as those who develop SARS-CoV-2 infection after the first dose but before receipt of the second dose. While there is otherwise no recommended minimum interval between infection and vaccination, current evidence<https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html> suggests that reinfection is uncommon in the 90 days after initial infection. Thus, persons with documented acute SARS-CoV-2 infection in the preceding 90 days may delay vaccination until near the end of this period, if desired.
For vaccinated persons who subsequently develop COVID-19, prior receipt of an mRNA COVID-19 vaccine should not affect treatment decisions (including use of monoclonal antibodies, convalescent plasma, antiviral treatment, or corticosteroid administration) or timing of such treatments.

For our organization we require:

·         Must be off quarantine

·         Must feel well

·         Must be educated to expect robust immune response, and per CDC you may defer your 2nd vaccine to 90 days.


From: MCOH-EH [mailto:mcoh-eh-bounces at mylist.net] On Behalf Of Jeremy Biggs via MCOH-EH
Sent: Thursday, January 07, 2021 3:55 PM
To: mcoh-eh at mylist.net
Cc: Jeremy Biggs
Subject: [MCOH-EH] COVID Vaccination Dose #2 in employees who become positive after dose #1

What are your policies for the following:

Employee has first vaccine and then becomes positive for COVID before the second dose. We have decided, based on the CDC site, COVID before or after 1st dose and before 2nd, don't need to interrupt the schedule, reschedule as long as symptoms resolved and at least 10 days from symptom onset or positive test in an asymptomatic employee.

I have talked with other institutions and some are postponing the second dose for 90 days from symptom onset or positive test in an asymptomatic positive. This they have said is to use the vaccine for others.

Anyone else doing anything different?



Jeremy Biggs MD MSPH FACOEM
Associate Professor

PPE “Czar”
University of Utah, Department of Family and Preventive Medicine
Rocky Mountain Center for Occupational and Environmental Health

Medical Director Rocky Mountain Specialty Services Clinic

Medical Director of the University Hospital and University Campus Employee Clinics

Medical Director of Occupational Medicine and Health, EHS and University Hospital and Clinics





DISCLAIMER:
The information transmitted is intended only for the person or entity to which it is addressed and may contain confidential and/or privileged material. Any review, retransmission, dissemination or other use of, or taking of any action in reliance upon, this information by persons or entities other than the intended recipient is prohibited.  If you received this in error, please contact the sender and delete the material from any computer.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://mylist.net/archives/mcoh-eh/attachments/20210108/4a34388d/attachment.htm>